Trials / Terminated
TerminatedNCT01712412
Phase 2a Study of IW-9179 to Treat Functional Dyspepsia
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Ironwood Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this study are to determine the safety and efficacy of IW-9179 administered to patients with functional dyspepsia (FD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IW-9179 | |
| DRUG | Placebo |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2014-02-01
- Completion
- 2014-03-01
- First posted
- 2012-10-23
- Last updated
- 2014-03-19
Locations
15 sites across 2 countries: Belgium, Netherlands
Source: ClinicalTrials.gov record NCT01712412. Inclusion in this directory is not an endorsement.